Canada Pension Plan Investment Board
BDTX icon

Canada Pension Plan Investment Board’s Black Diamond Therapeutics BDTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$450K Buy
211,400
+8,300
+4% +$19.7K ﹤0.01% 1273
2025
Q4 		$494K Buy
+203,100
New +$719K ﹤0.01% 1307

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Canada Pension Plan Investment Board's BDTX Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Black Diamond Therapeutics (BDTX) stake by 4.1% in Q1 2026, buying an estimated $19.7K and bringing the position to 211,400 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Canada Pension Plan Investment Board first reported a position in BDTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $494K in Q4 2025. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • Canada Pension Plan Investment Board held 211,400 shares of Black Diamond Therapeutics worth $450K as of Q1 2026.
  • Canada Pension Plan Investment Board bought 8,300 Black Diamond Therapeutics shares in Q1 2026, an estimated $19.7K.
  • Black Diamond Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1273 holding.
  • Canada Pension Plan Investment Board first reported a position in Black Diamond Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Canada Pension Plan Investment Board's Black Diamond Therapeutics position peaked at $494K in Q4 2025.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.